Aquestive Therapeutics (AQST) Return on Capital Employed Growth (1y) (2019 - 2026)
Aquestive Therapeutics (AQST) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1,195.00 |
| 10 | Aquestive Therapeutics | 459.79 Mn | 459.79 Mn | 13.47 Mn | 234.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 234.00 |
| Dec 31, 2025 | -2,668.00 |
| Sep 30, 2025 | -3,274.00 |
| Jun 30, 2025 | -5,646.00 |
| Mar 31, 2025 | -2,350.00 |
| Dec 31, 2024 | 220.00 |
| Sep 30, 2024 | 4,272.00 |
| Jun 30, 2024 | 12,468.00 |
| Mar 31, 2024 | 17,071.00 |
| Dec 31, 2023 | 24,413.00 |
| Sep 30, 2023 | 18,148.00 |
| Jun 30, 2023 | 1,879.00 |
| Mar 31, 2023 | -9,419.00 |
| Dec 31, 2022 | -19,856.00 |
| Sep 30, 2022 | -15,141.00 |
| Jun 30, 2022 | -4,982.00 |
| Mar 31, 2022 | -1,365.00 |
| Dec 31, 2021 | 3,745.00 |
| Sep 30, 2021 | 204.00 |
| Jun 30, 2021 | -3,755.00 |